Contact Us

Home Capabilities Localization

Localization

Building a Sustainable Pharmaceutical Future

Sudair Pharma was established with a clear objective: to localize the manufacturing of advanced pharmaceutical products in Saudi Arabia and contribute to a resilient healthcare ecosystem.
Localization Overview

International expertise, local capability

By combining international expertise with local manufacturing capabilities, Sudair Pharma is accelerating pharmaceutical localization while supporting national healthcare priorities, patient access, and economic development.

  • Supporting Saudi Vision 2030
  • Strengthening national drug security
  • Reducing dependence on imported medicines
  • Advancing local pharmaceutical manufacturing
  • Expanding high-technology production
  • Developing national scientific capabilities
Manufacturing plant exterior
A multi-pillar approach
Localization at Sudair Pharma extends beyond manufacturing. It is a comprehensive strategy built around innovation, partnerships, scientific development, and advanced production technologies.

  • Pillar 01

    Advanced Manufacturing

    Developing specialized pharmaceutical manufacturing capabilities for oncology, biologics, insulin, respiratory therapies, and other high-value medicines.

  • Pillar 02

    Technology Transfer

    Working with international pharmaceutical partners to transfer manufacturing knowledge, technical expertise, and production technologies into Saudi Arabia.

  • Pillar 03

    Scientific Collaboration

    Building partnerships with universities, research institutions, and healthcare organizations to strengthen pharmaceutical innovation and workforce development.

  • Pillar 04

    National Capability Development

    Investing in local talent, infrastructure, and advanced manufacturing technologies to build long-term pharmaceutical self-sufficiency.

14

 

Expanding local production across strategic therapeutic areas

Sudair Pharma is investing in specialized manufacturing facilities that support the localization of complex pharmaceutical products while meeting international quality standards.

Oncology Manufacturing

Saudi Arabia’s first specialized oncology manufacturing facility, producing advanced oncology and hematology medicines.

Insulin Manufacturing

Developing a comprehensive insulin manufacturing facility progressing from secondary packaging toward full formulation, filling, and commercial production.

Biosimilars & Monoclonal Antibodies

Building advanced biologics manufacturing capabilities for oncology, immunology, and chronic diseases.

Respiratory Manufacturing

Future production of inhalation therapies including dry-powder inhalers, metered-dose inhalers, soft-mist devices, and sterile nebulized solutions.

Collaborating to strengthen national healthcare

Sudair Pharma works with global pharmaceutical companies, government entities, healthcare organizations, and academic institutions to accelerate localization initiatives.

Localization partners

Local Content & Government Procurement AuthorityNUPCOInternational Pharmaceutical PartnersKing Saud UniversityPrincess Nourah bint Abdulrahman UniversityUniversity of Hafr Al-Batin

The Riyadh skyline with the Saudi flag. Partner organizations: NUPCO, International Pharmaceutical Partners, King Saud University, Princess Nourah bint Abdulrahman University.
Partnerships

Strategic Partnerships Supporting Localization

Collaborating to Strengthen National Healthcare

Sudair Pharma works with global pharmaceutical companies, government entities, healthcare organizations, and academic institutions to accelerate localization initiatives.

The Riyadh skyline with the Saudi flag. Partner organizations: NUPCO, International Pharmaceutical Partners, King Saud University, Princess Nourah bint Abdulrahman University.
Partnerships

Strategic Partnerships Supporting Localization

Collaborating to Strengthen National Healthcare

Sudair Pharma works with global pharmaceutical companies, government entities, healthcare organizations, and academic institutions to accelerate localization initiatives.

National capability, built to last

Reducing dependence on imported medicines through advanced local manufacturing.